Stock Ticker

  • Loading stock data...

Johnson & Johnson (NYSE:JNJ) Coronavirus Vaccine To Start Late-Stage Trial In September

A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the company said the phase three study will enroll 60,000 candidates aged 18 and above in around 180 locations in the U.S and abroad. Details released by the company indicate that […]

Johnson & Johnson (NYSE:JNJ) Targets at least 1 Billion Vaccines in 2021

Johnson & Johnson (NYSE:JNJ) is working on a vaccine with a goal of 1 billion tests in 2021. According to Dr. Paul Stoffels, the Chief Scientific Officer at J&J, the company “is increasing its manufacturing and preparing for clinical trials in September.” The clinical trials should provide sufficient data to facilitate development of the vaccines […]

Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020

Johnson & Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and Development Authority (BARDA) in the US. It is an extension of the existing accord between the Janssen Pharmaceutical Companies division of Johnson & Johnson and BARDA. The first batch of affordable […]

Johnson & Johnson (NYSE:JNJ) Fined $344 Million For Failing To Disclose Risks Of Pelvic Mesh Devices

Johnson & Johnson (NYSE:JNJ) has been ordered to pay over $340 million in penalties to the state of California following a ruling that the company employed deceptive and false marketing for its pelvic mesh product for women. J&J subsidiary failed to reveal risks of the pelvic mesh devices California Superior Court Judge Eddie Sturgeon delivered […]

pSivida Corp. (NASDAQ:PSDV) Elects Veteran Healthcare Executive To Its Board

pSivida Corp. (NASDAQ:PSDV) reported that it has elected Kristine Peterson, who is a seasoned healthcare executive, to its Board of Directors. Peterson has extensive pharma experience, having worked as the CEO of Valeritas from 2009 to 2016, a commercial-stage medical technology firm focused on simplifying life and improving health for people with diabetes. She has […]

3D Printing Technology May Not Be Common, But It will Get A New Face

The use of 3D printing technology is no longer common perhaps as a result of its high cost and slow pace. In fact, a lot of companies that have invested in it have hit real blocks including lack of manufacturing expertise which is very prevalent. But apparently, many people are interested in the technology according […]

Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky Attributes 3Q Results To Continued Success Of New Products And Strength In Core Business

Boston, MA 10/15/2014 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ) Chairman and CEO Alex Gorsky, said that its third-quarter financial results reflected the continued success of new products and the strength of core business. He also said that the company was making conscious choice of portfolio thereby positioning itself to achieve its short-term, as well as, […]

Gilead Sciences, Inc. (NASDAQ:GILD) Wins Street’s Hearts With Competitive Hepatitis C Drug Pricing

Boston, MA 10/13/2014 (wallstreetpr) – Gilead Sciences, Inc. (NASDAQ:GILD) is expected to reflect the positivity of the last week in its share prices today as well. The pharma company achieved a major milestone two days back when it recieved the U.S. Food and Drug Administration (FDA)’s nod for its hepatitis C drug. The regulatory approval […]

Trade Update: Marriott Vacations Worldwide Corp (NYSE:VAC); UTStarcom Holdings Corp (NASDAQ:UTSI); Johnson & Johnson (NYSE:JNJ)

Boston, MA 10/13/2014 (wallstreetpr) – Marriott Vacations Worldwide Corp (NYSE:VAC) announced on 10th October that it has completed the securitization of nearly “$250 million of vacation ownership loans”. The deal involved MVW Owner Trust buying nearly $205 million of the vacation loans on 9th October. It also retains an option to buy the reminder of […]

Johnson & Johnson (NYSE:JNJ) Could Fetch Up To $2 Billion From Cordis Sale

Boston, MA 09/02/2014 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ) plans to sell its medical devices business that makes items such as stents and catheters, stated Wall Street Journal in a recent article. The sale of the unit is expected to help JNJ further the slimming process of its wide-raging business portfolio. Sources said the sale […]

The Procter & Gamble Company (NYSE:PG): Probable Candidates for the CEO Post

Boston, MA 08/25/2014 (wallstreetpr) – Consumer packaged goods company, The Procter & Gamble Company (NYSE:PG), has been on a transition ever since current CEO, Allan G. Lafley, returned from retirement mandated with the responsibility of restoring the company’s growth metrics that was apparently stagnating according to USA Today. Since his return, Lafley has made management […]

Pfizer Inc. (NYSE:PFE) And Bristol-Myers Squibb Co (NYSE:BMY) Announced FDA Clearance For Eliquis For Blood Clots Treatment

Boston, MA 08/22/2214 (wallstreetpr) – Pfizer Inc. (NYSE:PFE) and Bristol-Myers Squibb Co (NYSE:BMY) announced recently that the USFDA has given an extension of approving Eliquis, the blood thinner, which shall be used for the treatment of fatal blood clots. The treatment of two kinds of blood clots can be done by way of this blood […]

BIOLASE Inc (NASDAQ:BIOL) Management Changes Announcement Boosts Stock Price

Boston, MA 06/18/2014 (wallstreetpr) – Leading manufacturer and distributor of dental lasers, BIOLASE Inc (NASDAQ:BIOL) announced significant changes in the management with the objective of strengthening its leadership, global competitiveness, and its focus towards professional customers, as well as, their patients. The changes were made following the Delaware Supreme Court order on June 12 on […]

Most Mentioned Stocks: Altria Group Inc (NYSE:MO), Health Care REIT, Inc. (NYSE:HCN), Pharmacyclics, Inc. (NASDAQ:PCYC)

Boston, MA 06/03/2014 (wallstreetpr) – Altria Group Inc (NYSE:MO) will pay a quarterly dividend of $0.48 per share on July 10, to shareholders who will have acquired its share by June 16. The newly declared quarterly dividend represents 4.73 percent on annualized basis.  The company has kept a good fight in the cigarette industry, and […]

Goldman Sachs Group Inc (NYSE:GS) Expects Johnson & Johnson (NYSE:JNJ) To Gain From Convincing Growth Potential In Emerging Markets

Boston, MA 05/28/2014 (wallstreetpr) – Investment brokerage Goldman Sachs Group Inc. (NYSE:GS) sees enough opportunities for Johnson & Johnson (NYSE:JNJ), the manufacturer of a wide range of products, to gain from emerging markets’ growing potential for its future growth and also sees it as a high priority for the healthcare company. Emerging Markets Johnson & […]

Sign Up To Get Our Latest Stocks Alerts